Anuh Pharma Ltd
ANUH

Anuh Pharma Ltd (506260)

₹92.553.2%

Key Stats

₹90.2
Day's Price Range
₹96.8
₹82.5
52-Week Price Range
₹149.9
1 Month Return6.51 %
3 Month Return3.51 %
1 Year Return-35.04 %

Company Financials

  • Annual
Value in ₹ crore

Peer Comparsion

PE
Rank 296
EPS
Rank 300
BVPS
Rank 319
Dividend Yield
Rank 180
ROE
Rank 197
12.75%
Price To Book Ratio
Rank 260
Debt To Asset
Rank 319

Company Information

Anuh Pharma Ltd is one of the leading manufacturers of Active Pharmaceutical Ingredients APIs. The company offers bulk drugs and chemicals. Their products are antibiotics erythromycin salts chloramphenicol and other chemicals. The company is part of the SK Group.Anuh Pharma Ltd was incorporated on February 19 1960. The company is well positioned to service their existing and potential markets through their manufacturing operations at Tarapur in Maharashtra. All the facilities are built and operated according to cGMP. They also received plant approvals from several MNCs.The business headquarters of the firm is located in the commercial capital of India Mumbai. The company is a recognized export house and exports their products to Mexico Brazil Iran Bangladesh Colombia Germany Africa Singapore and several other countries.During the year 200607 the company commissioned the new plant with all latest modern techniques and facilities. Thus the production capacity of Antibiotics increased from 400000 Kg to 600000 Kg.During the year 200809 the company completed the ongoing expansion of their plant thus they increased the installed capacity by 150 MT per annum. In September 2008 they expanded unit started commercial production.In January 2010 the company received approval for their product Erythromycin E.P. from European Directorate for the Quality of Medicines HealthCare EDQM. This approval paves the way for the company to sell Erythromycin E.P. in European counties for their own consumption.In April 2010 the company received approval for their product Pyrazinamide from European Directorate for the Quality of Medicines HealthCare EDQM. This approval paves the way for the company to sell Pyrazinamide in European countries for their own consumption.In June 2010 the company received approval for their product Clobetasol Propionate from European Directorate for the Quality Medicines Healthcare. This approval paves the way for the company to sell Clobetasol Propionate in European counties for their own consumption.
OrganisationAnuh Pharma Ltd
HeadquartersMumbai
IndustryPharmaceuticals